Article Text


1778 Predicting Failure of the Intubation-Surfactant-Extubation Procedure in very Preterm Infants
  1. N Brix,
  2. A Sellmer,
  3. MS Jensen,
  4. TB Henriksen
  1. Perinatal Epidemiology Research Unit, Department of Paediatrics, Aarhus University Hospital, Aarhus, Denmark


Background and Aims Respiratory Distress Syndrome can be treated with the INtubation-SURfactant-Extubation procedure (INSURE). INSURE-failure, with the need for re-intubation and mechanical ventilation, is common. We studied predictors of INSURE-failure to identify high-risk neonates that may benefit from staying intubated and mechanically ventilated after surfactant.

Methods We studied 363 very preterm infants (< 32 weeks) born 1998–2010 and treated with surfactant. Data were systematically retrieved from their medical records. We defined INSURE as extubation within 2 hours of intubation, and INSURE-failure as re-intubation within 72 hours.

Results Currently 219 of these 363 patients have been assessed; 96 were treated with INSURE (Table) and 123 needed prolonged mechanical ventilation. Newborns treated with INSURE had a median gestational age of 29 weeks and a median birth weight of 1158g.

Abstract 1777 Table 1

Conclusion These preliminary results suggest an increased risk of INSURE-failure in infants with a gestational age < 28 weeks, 5 minutes APGAR < 10, and surfactant administration in the delivery room. Keeping these newborns intubated after surfactant may prevent a high-risk re-intubation.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.